Foresight Autonomous (FRSX) director details vested stock options on Form 3

Rhea-AI Filing Summary

Foresight Autonomous Holdings Ltd. director Avidan Daniel reported existing holdings of stock options on Ordinary Shares. These options give him the right to buy 42,714 shares and 57,143 shares at an exercise price of 1.1200 per share.

The 42,714-share options expire on July 16, 2027 and were granted on July 16, 2020, fully vesting by December 31, 2022. The 57,143-share options expire on July 27, 2030 and were granted on July 27, 2023, fully vesting by June 30, 2026. The company’s securities are also listed as American Depository Shares, where one ADS represents 90 Ordinary Shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Avidan Daniel

Role Director

Type	Security	Shares	Price	Value
holding	Stock Options (Right to buy)	--	--	--
holding	Stock Options (Right to buy)	--	--	--

Holdings After Transaction: Stock Options (Right to buy) — 42,714 shares (Direct)

Footnotes (1)

1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date. The options were granted on July 16, 2020 and fully vested as of December 31, 2022. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026. The options were granted on July 27,2023 and fully vested as of June 30, 2026. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

Key Figures

Option exercise price: 1.1200 per share Underlying shares (2027 options): 42,714 shares Underlying shares (2030 options): 57,143 shares +3 more

6 metrics

Option exercise price 1.1200 per share Exercise price for reported stock options after conversion

Underlying shares (2027 options) 42,714 shares Ordinary Shares underlying options expiring July 16, 2027

Underlying shares (2030 options) 57,143 shares Ordinary Shares underlying options expiring July 27, 2030

ADS to Ordinary Share ratio 1 ADS = 90 Ordinary Shares Listing structure for the issuer’s securities

Original exercise price NIS 3.50 Original option exercise price before conversion using 3.119 ratio

Conversion ratio 3.119 Ratio used to convert NIS 3.50 exercise price as of March 16, 2026

Key Terms

Stock Options (Right to buy), Ordinary Shares, American Depository Shares ("ADS"), exercise price, +1 more

5 terms

Stock Options (Right to buy) financial

"security_title: "Stock Options (Right to buy)""

Ordinary Shares financial

"underlying_security_title: "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

American Depository Shares ("ADS") financial

"The Issuer's securities are listed as American Depository Shares ("ADS")"

exercise price financial

"The options were granted with an exercise price of NIS 3.50"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

fully vested financial

"The options were granted on July 16, 2020 and fully vested as of December 31, 2022."

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Avidan Daniel

(Last) (First) (Middle)

C/O FORESIGHT AUTONOMOUS

7 GOLDA MEIR ISRAEL

(Street)

NESS ZIONA 7414001

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Foresight Autonomous Holdings Ltd. [ FRSX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Options (Right to buy)	(2)	07/16/2027	Ordinary Shares(1)	42,714	$1.12(3)	D
Stock Options (Right to buy)	(4)	07/27/2030	Ordinary Shares	57,143	$1.12(5)	D

Explanation of Responses:

1. The Issuer's securities are listed as American Depository Shares ("ADS"), where one ADS represents 90 Ordinary Shares. Each ADS is convertible at any time, at the holder's election. The ADSs have no expiration date.

2. The options were granted on July 16, 2020 and fully vested as of December 31, 2022.

3. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

4. The options were granted on July 27,2023 and fully vested as of June 30, 2026.

5. The options were granted with an exercise price of NIS 3.50 and have been converted based on the ratio of 3.119 as of March 16, 2026.

	/s/ Daniel Avidan	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Foresight Autonomous (FRSX) director Avidan Daniel report on this Form 3?

He reports existing holdings of stock options on Ordinary Shares, not new trades. These options cover 42,714 and 57,143 underlying shares at a 1.1200 per-share exercise price, with expirations in July 2027 and July 2030 and full vesting already completed.

How many Foresight Autonomous (FRSX) shares are covered by Avidan Daniel’s stock options?

His reported options relate to two grants on Ordinary Shares. One grant covers 42,714 underlying shares expiring July 16, 2027, and the other covers 57,143 underlying shares expiring July 27, 2030, giving him rights to purchase these shares at a fixed exercise price.

What is the exercise price of Avidan Daniel’s FRSX stock options?

Both option grants show an exercise price of 1.1200 per share after conversion. Footnotes explain the options were originally granted with a NIS 3.50 exercise price and converted using a 3.119 ratio as of March 16, 2026 for reporting purposes.

When do Avidan Daniel’s FRSX stock options vest and expire?

The options granted July 16, 2020 fully vested by December 31, 2022 and expire July 16, 2027. The options granted July 27, 2023 fully vested by June 30, 2026 and expire July 27, 2030, defining the windows during which he can exercise them.

How are Foresight Autonomous (FRSX) Ordinary Shares related to its American Depository Shares (ADS)?

One ADS represents 90 Ordinary Shares, according to the disclosure. Each ADS is convertible at any time at the holder’s election, and the ADSs have no expiration date. This ratio helps investors translate between ADS trading and the underlying Ordinary Shares.